Skip to main content
OpenTrials

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,073 public trials 1,365 recruiting studies
Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Active, Not Recruiting

Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer

NCT05456685

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • University of Arizona Cancer Center /ID# 268906 Tucson, Arizona, United States
  • Women'S Cancer Research Network - Cogi /ID# 268912 Fresno, California, United States
  • Providence - St. Jude Medical /ID# 268911 Fullerton, California, United States
  • Moores Cancer Center /ID# 268888 La Jolla, California, United States
View all 69 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy of Mitazalimab in Combination With Chemotherapy in Pancreatic Cancer Patients

NCT04888312

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Cliniques Universitaires St-Luc Brussels, Belgium
  • Hospital Erasme Brussels, Belgium
  • UZA Antwerp Edegem, Belgium
  • Universitair Ziekenhuis Gent Ghent, Belgium
View all 14 locations
View Trial Details
Active, Not Recruiting

PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer

NCT04544111

Conditions
Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +22 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes

NCT02917798

Conditions
Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, +24 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Active, Not Recruiting

Trial on Radical Upfront Surgery in Advanced Ovarian Cancer

NCT02828618

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Medical University of Vienna Vienna, Austria
  • University Hospital, Rigshospitalet Copenhagen, Denmark
  • Institut Bergonié Bordeaux, France
View all 20 locations
View Trial Details
Active, Not Recruiting

Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer

NCT03563248

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • The Johns Hopkins Hospital Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1

NCT03785249

Conditions
Advanced Cancer, Colonic Diseases, Colonic Neoplasms, +20 more
Locations
  • Local Institution - 001-826 Birmingham, Alabama, United States
  • Local Institution - 001-965 Anchorage, Alaska, United States
  • Local Institution - 001-821 Phoenix, Arizona, United States
  • Local Institution - 001-873-A Tucson, Arizona, United States
View all 222 locations
View Trial Details
Active, Not Recruiting

A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy

NCT03690388

Conditions
Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +13 more
Locations
  • Exelixis Clinical Site #2 Newport Beach, California, United States
  • Exelixis Clinical Site #98 Sacramento, California, United States
  • Exelixis Clinical Site #69 San Francisco, California, United States
  • Exelixis Clinical Site #10 Stanford, California, United States
View all 164 locations
View Trial Details

Related conditions